China Shineway Pharmaceutical Group (CSWYY) Stock Price, News & Analysis

Company Overview

China Shineway Pharmaceutical Group develops, manufactures and sells pharmaceutical products, with a focus on traditional Chinese medicine and Chinese patent medicines. Its products are available in multiple dosage forms, including injections, tablets, capsules and oral preparations.

The company serves the healthcare market in China and is known for products used in areas such as cardiovascular care and respiratory conditions. Its portfolio includes traditional Chinese medicine injection products, alongside other medicines.

China Shineway was established in the early 1990s and is headquartered in Shijiazhuang, Hebei Province. The company was founded by Li Zhenjiang, who has been associated with its leadership.

Key Stats

• Today's Range: C$17.62 to C$17.62
• 50-Day Range: C$16.79 to C$21.49
• 52-Week Range: C$16.79 to C$22.23
• Volume: N/A
• Average Volume: 564 shs
• Market Capitalization: N/A
• P/E Ratio: 1.04
• Dividend Yield: 24.89%
• Price Target: N/A
• Consensus Rating: N/A

China Shineway Pharmaceutical Group Stock Analysis - MarketRank™

China Shineway Pharmaceutical Group scored higher than 7% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for China Shineway Pharmaceutical Group.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of China Shineway Pharmaceutical Group is 1.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.27.

Price to Earnings Ratio vs. Sector

The P/E ratio of China Shineway Pharmaceutical Group is 1.04, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.34.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

China Shineway Pharmaceutical Group has a short interest ratio ("days to cover") of 155, which indicates bearish sentiment.

Change versus previous month

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

China Shineway Pharmaceutical Group pays a meaningful dividend of 2.29%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

China Shineway Pharmaceutical Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of China Shineway Pharmaceutical Group is 25.79%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: N/A

News Sentiment

China Shineway Pharmaceutical Group has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Healthcare companies.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, China Shineway Pharmaceutical Group insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.01% of the stock of China Shineway Pharmaceutical Group is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:CSWYY
• CIK: N/A
• Web: www.shineway.com.hk
• Phone: 86 31 1880 30066
• Fax: N/A
• Employees: 2,822
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 1.04
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A